AEGISVOPAK - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 2.4
| Stock Code | AEGISVOPAK | Market Cap | 21,010 Cr. | Current Price | 190 ₹ | High / Low | 302 ₹ |
| Stock P/E | 118 | Book Value | 42.2 ₹ | Dividend Yield | 0.00 % | ROCE | 6.53 % |
| ROE | 7.70 % | Face Value | 10.0 ₹ | DMA 50 | 198 ₹ | DMA 200 | 226 ₹ |
| Chg in FII Hold | -0.14 % | Chg in DII Hold | -0.09 % | PAT Qtr | 51.1 Cr. | PAT Prev Qtr | 49.0 Cr. |
| RSI | 47.8 | MACD | 0.99 | Volume | 33,26,542 | Avg Vol 1Wk | 13,88,116 |
| Low price | 158 ₹ | High price | 302 ₹ | PEG Ratio | 0.32 | Debt to equity | 0.40 |
| 52w Index | 22.0 % | Qtr Profit Var | 50.3 % | EPS | 1.65 ₹ | Industry PE | 55.8 |
📊 Financials: ROE (7.70%) and ROCE (6.53%) are weak, showing poor efficiency in capital utilization. Debt-to-equity ratio of 0.40 indicates moderate leverage. PAT improved slightly from ₹49 Cr. to ₹51.1 Cr., but EPS remains very low at ₹1.65, reflecting limited profitability.
💹 Valuation: Current P/E of 118 is extremely high compared to industry average (55.8), signaling severe overvaluation. PEG ratio of 0.32 suggests undervaluation relative to growth, but weak fundamentals undermine this. P/B ratio (~4.5) is stretched against book value ₹42.2.
🏢 Business Model: AEGISVOPAK operates in logistics and chemical storage, benefiting from infrastructure scale. However, profitability metrics are weak, and lack of dividend yield reduces shareholder returns. Competitive advantage is limited by poor capital efficiency.
📈 Entry Zone: Fair entry closer to ₹160–175, near support levels (DMA 50 at ₹198, low price ₹158). Current price ₹190 is above fair accumulation zone, making cautious entry advisable only at lower levels.
📌 Long-Term Holding: Not ideal for long-term investors at current valuations. Weak fundamentals and poor return metrics suggest limited upside unless profitability improves significantly.
Positive
- PEG ratio of 0.32 indicates potential undervaluation relative to growth
- Quarterly profit variation at 50.3% shows some momentum
- Moderate debt-to-equity ratio (0.40) is manageable
Limitation
- Extremely high P/E ratio (118) vs industry average (55.8)
- Weak ROE (7.70%) and ROCE (6.53%)
- No dividend yield, reducing investor appeal
- EPS of ₹1.65 reflects poor earnings power
Company Negative News
- Institutional selling: FII holdings decreased by -0.14% and DII holdings by -0.09%
Company Positive News
- Quarterly PAT growth from ₹49 Cr. to ₹51.1 Cr.
- Volume activity surged (33.2 lakh vs avg 13.8 lakh), showing investor interest
Industry
- Logistics and chemical storage sector expanding with industrial demand
- Industry P/E at 55.8, indicating moderate valuations compared to company’s extreme premium
Conclusion
AEGISVOPAK is severely overvalued with weak fundamentals, low profitability, and no dividend yield. Entry is recommended only near ₹160–175 for speculative accumulation. Long-term holding is risky unless operational efficiency and earnings improve substantially.